According to a recently research report published by BriskInsights.com, the global Botanical And Plant Drugs Market is expected to grow at the CAGR of 6.8% during 2015-2022. The segmentation of global botanical and plant drugs market is based on therapeutic and geography. The report on Global botanical and plant drugs market forecast, 2015-2022 (by therapeutic and geography) provides detailed overview and predictive analysis of the market.
Full report available Global botanical and plant drugs market forecast, 2015-2022 (by therapeutic and geography) report at http://www.briskinsights.com/report/botanical-and-plant-derived-drug-market
Increasing demand for homeopathic and ayurvedic medicines for the cure of various chronic diseases are expected to boost the global botanical and plant derived drug market during the forecasted period of the study. The increasing demand in the health care industry for botanical drugs is also anticipated to have a significant impact on the growth of botanical drug market. Technological advancements in production process and increasing prevalence of chronic diseases have also contributed significantly towards the growth of these drugs. Some of the challenges faced by the global botanical and plant drugs market are low awareness level among the people and availability of alternative substitutes. This results in highly competitive scenario in the drugs market.
Scope of the report
1. Global botanical and plant drugs market by therapeutic applications, 2012 – 2022 ($ billion)
1.1. Hormone diseases
1.2. Infectious diseases
1.3. Pain and central nervous system disorder
1.4. Cardiovascular and metabolic diseases
1.5. Respiratory and oncology diseases
2. Global botanical and plant drugs market by types of plant drugs, 2012 – 2022 ($ billion)
3. Global high performance ceramic coatings regional outlook, 2012-2022(in $billion)
3.1. North America
3.3. Asia Pacific
3.4. Middle East & Africa
3.5. Latin America
4. Company profiles
4.1. Abbott Laboratories
4.2. Bayer Healthcare
4.4. Bristol Myers
4.5. Eli Lilly
4.7. Glenmark Pharmaceuticals Ltd.
4.8. Johnson And Johnson
4.9. Lupin Ltd.
4.11. Novartis International AG
4.13. Piramal Phytocare Ltd.
4.14. Ranbaxy Laboratories Ltd.
4.15. Tasly Pharmaceuticals Inc.
For More Information, List of Figure, Tables And TOC Visit – http://www.briskinsights.com/report/botanical-and-plant-derived-drug-market
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies. Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.
Web: Brisk Insights
Company Name: Brisk Insights
Contact Person: Jennifer Smith, Manager – Sales
Phone: +448081890034 (UK)
Address:Office 1094 109 Vernon House Friar Lane
Country: United Kingdom